Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07318467
Eligibility Criteria:
Inclusion Criteria:
* Women undergoing C-Sections.
* Women between the ages of 18 and 45 years.
* Singleton pregnancy.
* Gestational age is equal to or more than 36 weeks.
* No known coagulopathy or bleeding disorders.
* No known hypersensitivity or allergy to drugs used in the study.
* Normal obstetric ultrasonography with no fetal abnormalities.
Exclusion Criteria:
* Hemodynamically unstable or immobile patients.
* Multifetal pregnancy.
* Patients who are receiving prophylactic or therapeutic anticoagulation.
* Known comorbidities and contraindications to the use of Ergot derivatives or Carbetocin such as hypertension or cardiovascular disorders.
* Placenta previa and/or Placenta accreta spectrum.
* History of thromboembolism.
* Preeclampsia or eclampsia.
* Any additional measurements needed to control or stop excessive bleeding intraoperatively such as uterine artery ligation or use of sterile gelatin absorbable foam.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT07318467
Study Brief:
Protocol Section:
NCT07318467